An Italian success
Eurospital’s journey has always been full of challenges and success in the pharmaceutical and diagnostic market, yesterday as well as today.
Eurospital was established in Trieste in 1948 and since then it has maintained its original imprint, thanks to the management continuity of the Kropf family, who has been running the company for three generations.
Today, 70 years later, we at Eurospital keep looking at the future, searching for “innovation for living better”, in line with the company’s philosophy.
1948Eurospital was established in Trieste thanks to the intuition, vision, and entrepreneurial skills of its founder, Giorgio Kropf
1986Beginning of our diagnostic research and development activities
1988Creation of three new Divisions: Pharmaceutical, Diagnostic, and Hospital
1990Acquisition of major brands and the relative marketing authorisation of pharmaceutical products, including intravenous solutions, Haliborange, Dequadin, etc.
1995UNI EN ISO 9001 certification
1997Exclusive patent license for using Tissue Transglutaminase as a marker for diagnosing celiac disease
2008Creation of Piaceri Mediterranei, the range of gluten-free food resulting from the experience gained in celiac disease field
2013We were the first company to receive the FDA certification for the Calprotectin test for diagnosing Chronic Intestinal Inflammatory Diseases (CIID)
2017Eurospital is the first healthcare company in Italy to obtain the TÜV America certification for the US and Canadian markets within the MDSAP
2018Eurospital celebrates its 70th anniversary
2021Eurospital constantly supports Italian laboratories and pharmacies against SarsCov2